X
07Jan

DEAL WATCH: End-of-Year Biosimilar Agreements

Goodwin | | Return|
Following the string of biosimilar agreements announced in early November, a number of additional transactions were announced in early December, bringing 2019 to a roaring close with global biosimilars deals. On December 1, 2019, Luye Pharma Group...
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/deal-watch-end-of-year-biosimilar-10061/

Related

SEC’s Whistleblower Program Reaches New Heights

The Securities and Exchange Commission (SEC) announced an award to an overseas whistleblower, with t...

Read More >

If Pain (or Anything Else), Yes Gain—Part 76: Nevada Labor Commissioner’s Office Releases Guidance on Paid Leave Law

Seyfarth Synopsis: In June 2019, the Nevada Paid Leave Law (“PTO Law”) went into effect “for the ...

Read More >

Significant update to Australia's foreign investment framework

On 5 June 2020, the Treasurer of Australia announced reforms to Australia's foreign investment frame...

Read More >

Baltimore County Gets Ready for 2020 Comprehensive Zoning Map Process

In September 2019, Baltimore county will kick off the Comprehensive Zoning Map Process (“CZMP”).  ...

Read More >

Supreme Court of Kentucky Rules That Firms May Require Lawyers to Sign Non-Solicitation Agreements That Exempt Legal Work

A law firm can terminate an at-will lawyer who refuses to sign an agreement prohibiting them from so...

Read More >

Retail and Consumer Products Law Roundup - January 2020

Washington Legislature Resumes Consideration of the Washington Privacy Act - On January 14, a new v...

Read More >